Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages 139-

  Ogwang, Sam ^a,f   Asiimwe, Benon B ^b   Traore, Hamidou ^c   Mumbowa, Francis ^a,h   Okwera, Alphonse ^d   Eisenach, Kathleen D ^e   Kayes, Susan ^a,f   Jones López, Edward C ^g,h   McNerney, Ruth ^c   Worodria, William ^h   Ayakaka, Irene ^h   Mugerwa, Roy D ^d,f   Smith, Peter G ^c   Ellner, Jerrold ^g,h   Joloba, Moses L ^b,f  

^a JOINT CLINICAL RESEARCH CENTRE   (Uganda)

^b MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

^g UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^h MAKERERE UNIVERSITY   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; COST; DISINFECTION; HUMAN; INTERMETHOD COMPARISON; LABORATORY INFECTION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REPRODUCIBILITY; RETREATMENT; SENSITIVITY AND SPECIFICITY; SPUTUM SMEAR; UGANDA; ANALYTICAL EQUIPMENT; COMPARATIVE STUDY; ECONOMICS; FEASIBILITY STUDY; ISOLATION AND PURIFICATION; LUNG TUBERCULOSIS; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANT TUBERCULOSIS; SPUTUM;

ANTIBIOTICS, ANTITUBERCULAR; FEASIBILITY STUDIES; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; REAGENT KITS, DIAGNOSTIC; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; UGANDA;

EID: 70349764940     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-139     Document Type: Article

References (34)

1. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003, 163(9):1009-1021. 10.1001/archinte.163.9.1009, 12742798.
2. World Health Organisation Global tuberculosis control: surveillance, planning, financing. 2009, Geneva: WHO.
3. Guwatudde D, Zalwango S, Kamya MR, Debanne SM, Diaz MI, Okwera A, Mugerwa RD, King C, Whalen CC. Burden of tuberculosis in Kampala, Uganda. Bull World Health Organ 2003, 81(11):799-805. 2572356, 14758406.
4. CDC Notice to Readers: Revised Definition of Extensively Drug-Resistant Tuberculosis. JAMA 2006, 296(23):2792.
5. Zager EM, McNerney R. Multidrug-resistant tuberculosis. BMC Infect Dis 2008, 8:10. 10.1186/1471-2334-8-10, 2241599, 18221534.
6. Case definition for extensively drug-resistant tuberculosis. Wkly Epidemiol Rec 2006, 81(42):408.
7. Extensively drug-resistant tuberculosis - United States, 1993-2006. MMWR Morb Mortal Wkly Rep 2007, 56(11):250-253.
8. Sakoane R. XDR-TB in South Africa: back to TB sanatoria perhaps?. PLoS Med 2007, 4(4):e160. 10.1371/journal.pmed.0040160, 1876418, 17455995.
9. Temple B, Ayakaka I, Ogwang S, Nabanjja H, Kayes S, Nakubulwa S, Worodria W, Levin J, Joloba M, Okwera A. Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda. Clin Infect Dis 2008, 47(9):1126-1134. 10.1086/592252, 18808360.
10. Center for Disease Control and Prevention Epidemiologic notes and reports nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons-Florida and New York, 1988-1991. Morb Mortal Wkly Rep 1991, 40:585-591.
11. Center for Disease Control and Prevention Transmission of multi-drug-resistant tuberculosis among immunocompromised persons in a correctional system-New York, 1991. Morb Mortal Wkly Rep 1992, 41:507-509.
12. Sharp V, Sepkowitz KA, Lockhart B. Survival with MDR-TB and AIDS depends on proper selection of initial therapy. The Eighth International Symposium on Infections in the Immunocompromised Host: June 19-22 1994; Davos, Switzerland 1994,
13. Telzak E, Turett G, Torian L, Fazal B, Weisfuse I. Multidrug-resistant tuberculosis (MDRTB) in the South Bronx, New York City: clinical characteristics and improved outcome. The Eighth International Symposium on Infections in the Immunocompromised Host: June 19-22 1994; Davos, Switzerland 1994,
14. Joloba ML, Whalen CC, Cave DM, Eisenach KD, Johnson JL, Okwera A, Morrissey A, Bajaksouzian S, Feagin J, Mugerwa R. Determination of drug susceptibility and DNA fingerprint patterns of clinical isolates of Mycobacterium tuberculosis from Kampala, Uganda. East Afr Med J 2000, 77(2):111-115.
15. American, Thoracic, Society Diagnostic Standards and Classification of Tuberculosis in Adults and Children. Am J Respir Crit Care Med 2000, 161:1376-1395.
16. Siddiqi SH. BACTEC 460 TB System. Product and Procedure Manual. 1995, Sparks, MD: Becton Dickinson Diagnostic Instrument Systems.
17. Muhumuza J, Asiimwe BB, Kayes S, Mugyenyi R, Whalen C, Mugerwa RD, Boom H, Eisenach KD, Joloba ML. Introduction of an in-house PCR for routine identification of M. tuberculosis in a low-income country. Int J Tuberc Lung Dis 2006, 10(11):1262-1267.
18. Tortoli E, Mariottini A, Mazzarelli G. Evaluation of INNO-LiPA MYCOBACTERIA v2: improved reverse hybridization multiple DNA probe assay for mycobacterial identification. J Clin Microbiol 2003, 41(9):4418-4420. 10.1128/JCM.41.9.4418-4420.2003, 193803, 12958281.
19. Tortoli E, Nanetti A, Piersimoni C, Cichero P, Farina C, Mucignat G, Scarparo C, Bartolini L, Valentini R, Nista D. Performance assessment of new multiplex probe assay for identification of mycobacteria. J Clin Microbiol 2001, 39(3):1079-1084. 10.1128/JCM.39.3.1079-1084.2001, 87876, 11230430.
20. McNerney R. Phage replication technology for diagnosis and susceptibility testing. In Mycobacterium tuberculosis. 2001, 54. NY: Humana Press, Totowa.
21. McNerney R, Kambashi BS, Kinkese J, Tembwe R, Godfrey-Faussett P. Development of a bacteriophage phage replication assay for diagnosis of pulmonary tuberculosis. J Clin Microbiol 2004, 42(5):2115-2120. 10.1128/JCM.42.5.2115-2120.2004, 404598, 15131178.
22. Wanger A, Mills K. Etest for susceptibility testing of Mycobacterium tuberculosis and Mycobacterium avium-intracellulare. Diagn Microbiol Infect Dis 1994, 19(3):179-181. 10.1016/0732-8893(94)90064-7, 7821000.
23. Wanger A, Mills K. Testing of Mycobacterium tuberculosis susceptibility to ethambutol, isoniazid, rifampin, and streptomycin by using Etest. J Clin Microbiol 1996, 34(7):1672-1676. 229092, 8784567.
24. Hillemann D, Rusch-Gerdes S, Richter E. Evaluation of the GenoType MTBDRplus Assay for Rifampin and Isoniazid Susceptibility Testing of Mycobacterium tuberculosis Strains and Clinical Specimens. J Clin Microbiol 2007, 45(8):2635-2640. 10.1128/JCM.00521-07, 1951233, 17537937.
25. Miotto P, Piana F, Penati V, Canducci F, Migliori GB, Cirillo DM. Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. J Clin Microbiol 2006, 44(7):2485-2491. 10.1128/JCM.00083-06, 1489497, 16825369.
26. Lin SY, Probert W, Lo M, Desmond E. Rapid detection of isoniazid and rifampin resistance mutations in Mycobacterium tuberculosis complex from cultures or smear-positive sputa by use of molecular beacons. J Clin Microbiol 2004, 42(9):4204-4208. 10.1128/JCM.42.9.4204-4208.2004, 516347, 15365012.
27. Albert H, Trollip A, Seaman T, Mole RJ. Simple, phage-based (FASTPplaque) technology to determine rifampicin resistance of Mycobacterium tuberculosis directly from sputum. Int J Tuberc Lung Dis 2004, 8(9):1114-1119.
28. Traore H, Ogwang S, Mallard K, Joloba ML, Mumbowa F, Narayan K, Kayes S, Jones-Lopez EC, Smith PG, Ellner JJ. Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda. Ann Clin Microbiol Antimicrob 2007, 6:1. 10.1186/1476-0711-6-1, 1779803, 17212825.
29. Palaci M, Ueki SY, Sato DN, Da Silva Telles MA, Curcio M, Silva EA. Evaluation of mycobacteria growth indicator tube for recovery and drug susceptibility testing of Mycobacterium tuberculosis isolates from respiratory specimens. J Clin Microbiol 1996, 34(3):762-764. 228889, 8904457.
30. Lemus D, Montoro E, Echemendia M, Martin A, Portaels F, Palomino JC. Nitrate reductase assay for detection of drug resistance in Mycobacterium tuberculosis: simple and inexpensive method for low-resource laboratories. J Med Microbiol 2006, 55(Pt 7):861-863. 10.1099/jmm.0.46540-0, 16772412.
31. Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, Vivar A, Sanchez E, Pinedo Y, Saravia JC, Salazar C. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006, 355(15):1539-1550. 10.1056/NEJMoa055524, 1780278, 17035648.
32. Martin A, Camacho M, Portaels F, Palomino JC. Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method. Antimicrob Agents Chemother 2003, 47(11):3616-3619. 10.1128/AAC.47.11.3616-3619.2003, 253784, 14576129.
33. Traore H, van Deun A, Shamputa IC, Rigouts L, Portaels F. Direct detection of Mycobacterium tuberculosis complex DNA and rifampin resistance in clinical specimens from tuberculosis patients by line probe assay. J Clin Microbiol 2006, 44(12):4384-4388. 10.1128/JCM.01332-06, 1698436, 17035487.
34. El-Sayed Zaki M, Goda T. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB. Tuberculosis (Edinb) 2007, 87(2):102-108. 10.1016/j.tube.2006.05.002, 17035089.